Skip to main content
. 2021 Feb 25;12:147. doi: 10.1186/s13287-021-02215-x

Fig. 1.

Fig. 1

Characterization of control-MSCs and IPF-MSCs. a Surface markers of control-MSCs and IPF-MSCs were evaluated by flow cytometry. Both control-MSCs and IPF-MSCs expressed CD73, CD90, and CD105 but not CD34 or CD45. b Adipogenic differentiation evaluated by Oil Red staining and quantification of adipogenic efficiency in control-MSCs and IPF-MSCs. c Osteogenic differentiation determined by Alizarin red staining and quantification of osteogenic efficiency in control-MSCs and IPF-MSCs. d Chondrogenic differentiation determined by Alcian blue staining and quantification of chondrogenic efficiency in control-MSCs and IPF-MSCs. All data were obtained from at least three independent experiments and each error bar represents the mean ± SEM. Scale bar = 200 μm. ***p < 0 .001